Generex Biotechnology Corporation - Market Overview 2014

1. Generex Biotechnology Corporation - Product Pipeline Review - 2014 Order this report by calling +1 888 391 5441 or Send an email to sales@reportsandreports.com with your contact details and questions if any. Published: January 2014 Single User PDF: US$ 1500 Corporate User PDF: US$ 4500 © ReportsnReports.com / Contact sales@reportsandreports.com

2. Generex Biotechnology Corporation - Product Pipeline Review - 2014 Researcher’s pharmaceuticals report, "Generex Biotechnology Corporation Product Pipeline Review 2014" provides data on the Generex Biotechnology Corporation's research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from proprietary databases, Generex Biotechnology Corporation's corporate website, SEC filings, investor presentations and featured press releases, both from Generex Biotechnology Corporation and industry-specific third party sources, put together by Researching team. Inquiry Before Buying on this Report @ http://www.reportsnreports.com/contacts/inquirybeforebuy.aspx?name=274878 . Scope Generex Biotechnology Corporation Brief Generex Biotechnology Corporation overview including business description, key information and facts, and its locations and subsidiaries. Review of current pipeline of Generex Biotechnology Corporation human therapeutic division. Overview of pipeline therapeutics across various therapy areas. Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe. Order this report by calling +1 888 391 5441 or Send an email to sales@reportsandreports.com with your contact details and questions if any. © ReportsnReports.com / Contact sales@reportsandreports.com

3. Generex Biotechnology Corporation - Product Pipeline Review - 2014 Product profiles for late stage and clinical stage products of Generex Biotechnology Corporation with complete description of the product's developmental history, mechanism of action, therapeutic class, target and major milestones. Recent updates of the Generex Biotechnology Corporation's pipeline in the last quarter. Key discontinued and dormant projects. Latest news and deals relating to the products. Inquire for Discount @ http://www.reportsnreports.com/contacts/discount.aspx?name=274878 . Reasons to buy Evaluate Generex Biotechnology Corporation's strategic position with total access to detailed information on its product pipeline. Assess the growth potential of Generex Biotechnology Corporation in its therapy areas of focus. Identify new drug targets and therapeutic classes in the Generex Biotechnology Corporation's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas. Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps. Exploit collaboration and partnership opportunities with Generex Biotechnology Corporation. Avoid Intellectual Property Rights related issues. Order this report by calling +1 888 391 5441 or Send an email to sales@reportsandreports.com with your contact details and questions if any. © ReportsnReports.com / Contact sales@reportsandreports.com

4. Generex Biotechnology Corporation - Product Pipeline Review - 2014 Table of Contents Table of Contents 2List of Tables 4List of Figures 4Generex Biotechnology Corporation Snapshot 5Generex Biotechnology Corporation Overview 5Key Information 5Key Facts 5Generex Biotechnology Corporation - Research and Development Overview 6Key Therapeutic Areas 6Generex Biotechnology Corporation - Pipeline Review 9Pipeline Products by Stage of Development 9Pipeline Products - Monotherapy 10Generex Biotechnology Corporation - Pipeline Products Glance 11Generex Biotechnology Corporation - Late Stage Pipeline Products 11Phase III Products/Combination Treatment Modalities 11Generex Biotechnology Corporation - Clinical Stage Pipeline Products 12Phase II Products/Combination Treatment Modalities 12Phase I Products/Combination Treatment Modalities 13Generex Biotechnology Corporation - Early Stage Pipeline Products 14 Order this report by calling +1 888 391 5441 or Send an email to sales@reportsandreports.com with your contact details and questions if any. © ReportsnReports.com / Contact sales@reportsandreports.com

5. Generex Biotechnology Corporation - Product Pipeline Review - 2014 List of Tables Generex Biotechnology Corporation, Key Information 5Generex Biotechnology Corporation, Key Facts 5Generex Biotechnology Corporation - Pipeline by Indication, 2014 8Generex Biotechnology Corporation - Pipeline by Stage of Development, 2014 9Generex Biotechnology Corporation - Monotherapy Products in Pipeline, 2014 10Generex Biotechnology Corporation - Phase III, 2014 11Generex Biotechnology Corporation - Phase II, 2014 12Generex Biotechnology Corporation - Phase I, 2014 13Generex Biotechnology Corporation - Preclinical, 2014 14Generex Biotechnology Corporation - Pipeline by Therapeutic Class, 2014 29Generex Biotechnology Corporation - Pipeline by Target, 2014 30Generex Biotechnology Corporation - Pipeline by Route of Administration, 2014 31Generex Biotechnology Corporation - Pipeline by Molecule Type, 2014 32Generex Biotechnology Corporation - Pipeline Products by Mechanism of Action, 2014 33Generex Biotechnology Corporation - Recent Pipeline Updates, 2014 34 Contact sales@reportsandreports.com / Call +1 888 391 5441 for further information on “Generex Biotechnology Corporation - Product Pipeline Review - 2014” report OR for any other market research and intelligence needs you may have for your business. Order this report by calling +1 888 391 5441 or Send an email to sales@reportsandreports.com with your contact details and questions if any. © ReportsnReports.com / Contact sales@reportsandreports.com